Mesa Laboratories Inc
NASDAQ:MLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Mesa Laboratories Inc
Other Current Assets
Mesa Laboratories Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Other Current Assets
$9.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
13%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Current Assets
$960m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
1%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Current Assets
$474.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Current Assets
$1.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Current Assets
$2.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Current Assets
$376.4m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
18%
|
|
Mesa Laboratories Inc
Glance View
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.
See Also
What is Mesa Laboratories Inc's Other Current Assets?
Other Current Assets
9.9m
USD
Based on the financial report for Dec 31, 2025, Mesa Laboratories Inc's Other Current Assets amounts to 9.9m USD.
What is Mesa Laboratories Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
13%
Over the last year, the Other Current Assets growth was -25%. The average annual Other Current Assets growth rates for Mesa Laboratories Inc have been -6% over the past three years , 1% over the past five years , and 13% over the past ten years .